≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Pneumocystosis

EFO Endpoint Browser PheWeb

AB1_PNEUMOCYSTOSIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B59
  • Hospital discharge: ICD-9 — 1363
  • Hospital discharge: ICD-8 — 13601
  • Cause of death: ICD-10 — B59
  • Cause of death: ICD-9 — 1363
  • Cause of death: ICD-8 — 13601

2 out of 7 registries used, show all original rules.

657

4. Check minimum number of events

None

657

5. Include endpoints

None

657

6. Filter based on genotype QC (FinnGen only)

637

Control definitions (FinnGen only)

Control exclude
AB1_PROTOZOAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2264 930 1311
Only index persons 1857 788 1069
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.04 0.03 0.04
Median age at first event (years)
Whole population 65.64 66.13 65.45
Only index persons 67.08 67.10 67.08

-FinnGen-

Key figures

All Female Male
Number of individuals 637 287 350
Unadjusted period prevalence (%) 0.13 0.10 0.16
Median age at first event (years) 68.36 67.61 68.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
657
Matched controls
6570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
25.3
307.7
267
173
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
564
*
TGC00
NOMESCO Finland
Bronchial lavation
59.7
307.7
296
89
UGC12
NOMESCO Finland
Flexible bronchoscopy
20.1
307.7
328
311
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
19.5
268.6
246
196
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.9
262.4
227
162
J18.9
ICD-10 Finland
Pneumonia, unspecified
12.2
224.0
472
1136
R50.9
ICD-10 Finland
Fever, unspecified
9.6
186.7
323
602
ZX108
NOMESCO Finland
Inhalation
52.7
163.8
95
21
XW000
NOMESCO Finland
Bone marrow biopsy
14.1
160.4
165
153
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.9
158.2
260
448
L03AA02
ATC
filgrastim; parenteral
16.8
146.7
132
97
JN4AD
NOMESCO Finland
Body CT examination
8.2
139.5
242
437
WW500
NOMESCO Finland
Blood transfusion
13.0
137.7
147
143
B59
ICD-10 Finland
Pneumocystosis
+∞
128.4
119
*
ZX120
NOMESCO Finland
Intravenous
8.2
128.2
213
364
GD1AD
NOMESCO Finland
Thorax CT examination
9.9
127.5
170
224
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
18.4
121.5
102
65
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.4
119.8
223
428
H02AB06
ATC
prednisolone; systemic
8.2
115.8
541
2378
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.9
113.2
147
186
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.4
110.5
553
2543
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
13.9
100.0
98
82
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
24.4
98.9
72
33
A04AA01
ATC
ondansetron; systemic, rectal
7.3
98.3
172
305
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
7.2
98.1
173
309
H02AB02
ATC
dexamethasone; systemic
6.0
93.2
212
484
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.7
93.1
119
146
D70.82
ICD-10 Finland
Drug-induced neutropenia
19.1
92.5
75
44
L04AA06
ATC
mycophenolic acid; systemic
16.8
91.1
79
53
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.2
90.4
269
773
M04AA01
ATC
allopurinol; systemic
5.5
88.7
227
573
JN4BD
NOMESCO Finland
Extensive body CT
5.8
88.7
205
473
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.6
88.5
114
141
J01MA14
ATC
moxifloxacin; systemic
6.5
88.5
173
341
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
19.5
87.3
70
40
L03AA13
ATC
pegfilgrastim; parenteral
9.0
86.4
117
154
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.8
83.7
97
104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
82.1
133
215
127
Kela drug reimbursment
Transplant complication
17.9
81.6
68
42
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
79.8
291
967
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
14.9
77.9
72
54
Z51.5
ICD-10 Finland
Palliative care
6.2
77.2
155
311
L04AX01
ATC
azathioprine; systemic
9.6
74.8
94
112
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16.0
72.5
64
44
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.9
70.8
150
315
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.6
68.1
123
221
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.0
67.5
371
1611
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
27.4
66.6
46
18
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
19.1
66.1
53
30
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.2
66.0
85
104
J01FF01
ATC
clindamycin; systemic
3.8
62.3
307
1224
D70.89
ICD-10 Finland
Neutropenic splenomegaly
20.6
62.0
48
25
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.6
61.9
77
90
J01MA12
ATC
levofloxacin; systemic
4.0
61.4
243
833
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.9
60.7
160
403
C03CA01
ATC
furosemide; systemic
3.5
55.8
330
1457
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.7
55.7
155
406
L04AD01
ATC
ciclosporin; systemic
13.0
55.5
55
46
A04AA02
ATC
granisetron; systemic, transdermal
5.6
55.5
120
254
J05AB11
ATC
valaciclovir; oral
4.2
55.1
189
580
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
23.6
54.8
40
18
TK800
NOMESCO Finland
Hemodialysis
10.4
53.8
62
65
JN6AD
NOMESCO Finland
CT of torso and neck
12.2
53.3
55
49
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
53.2
181
551
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
23.7
52.1
38
17
WW200
NOMESCO Finland
Immunization
9.7
51.9
63
71
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
16.8
51.6
44
28
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
49.4
351
1700
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.6
46.3
41
28
N02AA05
ATC
oxycodone; systemic
3.5
46.1
219
826
L04AA01
ATC
[U] ciclosporin
17.5
45.6
38
23
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
45.5
249
1023
L03AA14
ATC
lipegfilgrastim; parenteral
10.4
45.3
52
54
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.9
44.8
64
88
A02BC02
ATC
pantoprazole; systemic
4.4
44.8
559
3714
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
13.6
42.9
41
32
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.6
42.1
51
57
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.1
41.6
96
213
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
9.8
39.6
47
51
L04AX03
ATC
methotrexate; systemic
4.2
39.5
122
341
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.5
39.4
48
54
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.0
39.4
92
206
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
39.4
202
789
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
12.5
38.0
38
32
ZX112
NOMESCO Finland
Subcutaneous
7.4
37.9
57
83
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.7
37.7
49
60
Z94.0
ICD-10 Finland
Kidney transplant status
14.2
37.6
35
26
R06.0
ICD-10 Finland
Dyspnoea
2.9
36.5
269
1279
L01BA01
ATC
methotrexate; systemic
7.0
36.4
58
90
A41.9
ICD-10 Finland
Sepsis, unspecified
6.2
35.9
65
115
WX892
NOMESCO Finland
Monitored bed care
4.2
35.2
104
280
A07AA09
ATC
vancomycin; oral
12.8
34.4
34
28
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.6
34.4
50
70
H02AB07
ATC
prednisone; oral
3.4
34.1
149
523
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.9
33.9
81
184
A07EC01
ATC
sulfasalazine; oral, rectal
4.3
33.8
97
255
L04AD02
ATC
tacrolimus; systemic
13.4
33.4
32
25
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.5
33.2
68
135
H02AB09
ATC
hydrocortisone; systemic
8.0
33.1
46
61
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.5
33.0
37
37
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
8.6
32.8
43
53
C90.0
ICD-10 Finland
Multiple myeloma
11.9
32.0
33
29
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.7
31.9
80
189
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.8
31.8
61
114
B03XA02
ATC
darbepoetin alfa; parenteral
7.4
31.3
47
68
B01AB10
ATC
tinzaparin; parenteral
3.5
31.1
123
404
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.4
30.9
130
444
A11CC03
ATC
alfacalcidol; systemic
7.4
30.0
45
65
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
10.2
28.8
33
34
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
28.5
407
2578
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
32.6
28.4
37
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
28.4
265
1381
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
28.1
109
352
M05BX04
ATC
denosumab; parenteral
4.3
28.1
79
204
L04AA13
ATC
[U] leflunomide
7.7
27.8
40
55
P01BA02
ATC
hydroxychloroquine; oral
3.7
27.8
96
287
H02AB04
ATC
methylprednisolone; systemic
3.0
27.6
146
569
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.0
27.6
84
230
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
27.5
82
221
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
10.1
27.0
31
32
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.2
26.9
77
201
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.7
26.6
51
95
Z2446
NOMESCO Finland
Social worker
4.0
26.4
83
232
1CX01, ,
NOMESCO Finland
62.7
26.2
30
5
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.3
26.1
32
36
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
26.0
95
295
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.8
25.9
49
90
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
6.3
25.9
45
76
A12AA04
ATC
calcium carbonate; oral
7.9
25.7
36
48
L04AB04
ATC
adalimumab; parenteral
9.2
25.2
31
35
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.1
25.2
74
197
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.1
25.0
74
198
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.3
24.5
42
70
WW300
NOMESCO Finland
Transfer of autologic stem cells
30.5
24.3
32
11
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
24.1
23
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
23.8
121
458
A05AA02
ATC
ursodeoxycholic acid; oral
8.9
23.8
30
35
WF004
NOMESCO Finland
Palliative radiotherapy
6.6
23.8
39
62
Z3231
NOMESCO Finland
Registered nurse
2.4
23.7
241
1285
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
23.7
112
407
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.7
23.7
28
30
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
23.6
127
496
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.9
23.6
37
56
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
23.6
328
1997
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.8
23.6
55
122
J05AB01
ATC
aciclovir; systemic
2.5
23.4
188
901
1XC02, ,
NOMESCO Finland
23.1
23.2
33
15
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.3
23.2
31
39
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
22.3
110
409
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.7
21.9
42
78
J96.0
ICD-10 Finland
Acute respiratory failure
8.4
21.9
29
36
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
21.9
177
847
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
21.9
105
384
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
21.0
120
483
ZXE00
NOMESCO Finland
One hour or less
2.2
20.9
297
1798
SPAT1255
SPAT
Intravenous administration of medicine
3.5
20.9
76
234
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
20.7
290
1746
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
20.6
168
804
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
43.2
20.6
25
6
R4110
NOMESCO Finland
Physiotherapy
2.2
20.3
237
1323
C83.1
ICD-10 Finland
Mantle cell lymphoma
33.8
20.3
26
8
R81
ICPC
Pneumonia
4.5
20.1
51
121
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.4
19.8
26
32
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.2
19.6
32
22
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.5
19.5
71
219
A04AA55
ATC
palonosetron, combinations; systemic
4.6
19.0
47
109
6BA02, ,
NOMESCO Finland
56.8
19.0
22
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
18.9
67
203
B01AB05
ATC
enoxaparin; parenteral
2.1
18.7
265
1587
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
103.0
18.7
20
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.5
18.6
31
50
J02AC03
ATC
voriconazole; systemic
31.1
18.4
24
8
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.8
18.4
29
44
WZC30
NOMESCO Finland
Teaching
2.4
18.2
146
691
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.6
18.1
62
183
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
34.0
18.1
23
7
A07AA02
ATC
nystatin; oral
3.5
18.0
65
199
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
18.0
148
708
B48.5
ICD-10 Finland
Pneumocystosis
+∞
17.8
17
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
37.9
17.7
22
6
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
13.6
17.6
30
23
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
17.5
218
1237
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.2
17.5
30
50
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
21.6
17.4
25
12
A46
ICD-10 Finland
Erysipelas
2.5
17.3
132
609
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.7
17.3
41
92
B03XA01
ATC
erythropoietin; parenteral
13.7
17.1
29
22
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.3
17.0
29
48
WX720
NOMESCO Finland
Own respiration
3.5
16.5
59
179
212
Kela drug reimbursment
Gout
5.9
16.5
30
53
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.3
16.4
66
216
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
16.2
212
1219
R03AC02
ATC
salbutamol; inhalant
2.0
16.2
389
2770
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.6
16.0
31
58
M05BA04
ATC
alendronic acid; oral
2.9
15.8
81
306
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
15.6
37
83
L88
ICPC
Rheumatoid/seropositive arthritis
4.0
15.3
44
115
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
20.6
15.2
22
11
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
15.2
93
385
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
14.4
15.1
25
18
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.8
15.0
48
135
ZXD05
NOMESCO Finland
Urgent procedure
2.0
15.0
223
1336
Z3226
NOMESCO Finland
Physiotherapist
2.2
15.0
154
804
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
14.9
47
131
WX726
NOMESCO Finland
High-flow oxygen therapy
58.1
14.8
17
*
R05
ICD-10 Finland
Cough
2.1
14.7
167
905
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
14.7
137
686
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.6
14.4
35
80
WX882
NOMESCO Finland
High dependency care
4.3
14.4
38
93
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
19.7
14.3
21
11
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
14.3
41
107
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
14.2
57
186
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.3
14.2
25
21
AA1AD
NOMESCO Finland
CT of head and brain
2.0
14.1
220
1335
A03
ICPC
Fever
2.3
14.1
121
584
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.4
14.1
27
27
A06AH03
ATC
naloxegol; oral
6.2
13.9
24
40
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
30.8
13.9
18
6
B02.9
ICD-10 Finland
Zoster without complication
2.9
13.9
69
255
J01CA04
ATC
amoxicillin; systemic
2.2
13.9
542
4458
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
13.8
118
569
N02AX02
ATC
tramadol; systemic, rectal
1.9
13.8
319
2201
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.4
13.8
35
83
Z2221
NOMESCO Finland
Medical doctor
2.0
13.7
200
1184
J01MA02
ATC
ciprofloxacin; systemic
1.9
13.7
287
1918
M01CB01
ATC
sodium aurothiomalate; parenteral
12.4
13.7
24
20
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.2
13.7
129
648
N18.8
ICD-10 Finland
Other chronic renal failure
4.7
13.7
32
71
A04AD12
ATC
aprepitant; systemic
4.9
13.7
30
63
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
13.6
290
1948
390
Kela drug reimbursment
Ibrutinib
34.8
13.6
17
5
L01AA01
ATC
cyclophosphamide; systemic
18.7
13.4
20
11
L01AA02
ATC
chlorambucil; oral
26.4
13.4
18
7
WW409
NOMESCO Finland
Other aferesis
26.4
13.4
18
7
XG410
NOMESCO Finland
Flow-volume spirometry
3.5
13.4
47
141
WX002
NOMESCO Finland
Sedation and analgesia
2.1
13.4
162
897
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.8
13.3
25
24
C82.1
ICD-10 Finland
Follicular lymphoma grade II
14.2
13.3
22
16
RD210, ,
NOMESCO Finland
5.9
13.3
24
42
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.3
13.3
27
53
R11
ICD-10 Finland
Nausea and vomiting
2.8
13.1
72
281
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
13.1
103
478
N18.0
ICD-10 Finland
End-stage renal disease
10.3
13.1
25
25
A10AC01
ATC
insulin (human); parenteral
2.8
13.1
70
270
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.7
13.0
42
119
J01DB01
ATC
cefalexin; oral
2.2
13.0
554
4634
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
13.3
13.0
22
17
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
51.1
12.9
15
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.6
12.7
42
121
3AC01, ,
NOMESCO Finland
15.8
12.7
20
13
R06AE07
ATC
cetirizine; oral
1.8
12.5
283
1922
153
Kela drug reimbursment
Lenalidomid
13.5
12.5
21
16
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
12.4
470
3731
C07AB07
ATC
bisoprolol; oral
1.8
12.4
365
2681
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
14.7
12.3
20
14
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
12.3
81
346
N05CF01
ATC
zopiclone; oral
1.9
12.3
230
1470
WX725
NOMESCO Finland
Noninvasive ventilation
3.0
12.3
57
203
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
12.3
200
1223
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
16.3
12.2
19
12
329
Kela drug reimbursment
Lenalidomide
18.5
12.1
18
10
E87.5
ICD-10 Finland
Hyperkalaemia
5.2
12.0
25
50
B34.9
ICD-10 Finland
Viral infection, unspecified
4.6
12.0
29
66
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.8
12.0
22
39
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
11.9
39
112
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.8
11.8
64
248
L04AB01
ATC
etanercept; parenteral
9.9
11.8
23
24
L04AX04
ATC
lenalidomide; oral
12.9
11.7
20
16
1512
Kela drug reimbursment
Ibrutinib
30.6
11.7
15
5
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
30.6
11.7
15
5
YNB10
NOMESCO Finland
Collection of stem cells for transplant
66.2
11.6
13
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
11.6
49
165
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
9.5
11.6
23
25
N02AA01
ATC
morphine; systemic, rectal
5.0
11.5
25
52
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
11.5
11
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.3
11.5
44
140
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.3
11.4
43
135
N19
ICD-10 Finland
Unspecified kidney failure
3.4
11.4
41
125
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
11.3
24
49
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.7
11.3
26
57
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
17.4
11.2
17
10
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.6
11.2
68
279
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
11.2
117
609
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.2
11.2
44
142
A10AB05
ATC
insulin aspart; parenteral
2.6
11.2
69
286
N03AX16
ATC
[U] pregabalin
1.9
11.1
175
1053
130
Kela drug reimbursment
Malignant tumour
2.4
11.0
84
384
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.5
10.9
21
39
A02BC01
ATC
omeprazole; systemic
1.8
10.9
199
1254
R4190
NOMESCO Finland
Nutritional therapy
3.4
10.8
39
119
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
18.2
10.8
16
9
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
28.6
10.8
14
5
D69.5
ICD-10 Finland
Secondary thrombocytopenia
28.6
10.8
14
5
R28
ICPC
Limited function/disability (R)
5.7
10.8
20
36
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.0
10.7
47
162
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.4
10.7
38
115
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
13.2
10.7
18
14
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.7
166
994
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
61.0
10.7
12
*
L01XE27
ATC
[U] ibrutinib
61.0
10.7
12
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
10.6
598
5275
L01CA04
ATC
vinorelbine; systemic
9.4
10.6
21
23
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
9.4
10.6
21
23
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
10.6
73
319
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.9
10.6
23
48
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
10.5
53
198
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
4.1
10.4
29
74
J04BA02
ATC
dapsone; oral
16.4
10.4
16
10
WX402
NOMESCO Finland
General anaesthesia
1.9
10.4
155
915
C83.00
ICD-10 Finland
Lymphocytic lymphoma
33.1
10.4
13
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
10.4
119
641
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
10.2
51
189
J02AC01
ATC
fluconazole; systemic
1.8
10.0
227
1519
M31.3
ICD-10 Finland
Wegener granulomatosis
17.0
9.9
15
9
399
Kela drug reimbursment
Venetoclax
17.0
9.9
15
9
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.9
262
1830
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
9.9
63
265
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
9.9
153
913
A02BC05
ATC
esomeprazole; systemic
1.7
9.8
277
1968
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.5
9.8
22
30
UJF32
NOMESCO Finland
Coloscopy
1.8
9.7
196
1267
HA1AA
NOMESCO Finland
X-ray mammography
2.5
9.7
62
261
WW400
NOMESCO Finland
Plasmaferesis
55.8
9.7
11
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
55.8
9.7
11
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.4
9.7
24
56
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
8.6
9.6
20
24
R03BA08
ATC
ciclesonide; inhalant
2.4
9.6
66
288
TAB00
NOMESCO Finland
Lumbar puncture
3.0
9.6
42
145
J96.1
ICD-10 Finland
Chronic respiratory failure
4.0
9.5
27
70
ZXA00
NOMESCO Finland
Right side
1.8
9.5
199
1300
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
9.4
9
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
9.4
68
304
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
9.2
136
797
A06AD11
ATC
lactulose; oral
2.0
9.2
110
600
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.6
9.2
30
86
E0000UV, ,
ATC
1.7
9.2
270
1931
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
9.1
55
225
137
Kela drug reimbursment
Uraemia requiring dialysis
8.5
9.1
19
23
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
9.2
9.1
18
20
1518, ,
Kela drug reimbursment
15.9
9.1
14
9
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
37.2
9.0
11
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
9.0
42
150
L01XX52
ATC
venetoclax; oral
18.9
9.0
13
7
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.0
8.9
25
64
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.9
145
875
L01BB05
ATC
fludarabine; systemic
24.4
8.9
12
5
L04AA24
ATC
abatacept; parenteral
24.4
8.9
12
5
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.4
8.9
22
51
B01AB04
ATC
dalteparin; parenteral
2.9
8.9
42
151
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.1
8.9
38
129
WX610
NOMESCO Finland
Patient controlled analgesia
12.8
8.9
15
12
V03AE02
ATC
sevelamer; oral
12.8
8.9
15
12
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.2
8.8
35
114
N17.8
ICD-10 Finland
Other acute renal failure
7.3
8.8
20
28
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
8.8
68
313
ZXA05
NOMESCO Finland
Left side
1.7
8.7
181
1175
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.5
8.7
21
48
J12.8
ICD-10 Finland
Other viral pneumonia
8.4
8.6
18
22
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
8.6
132
782
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.1
8.6
23
57
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
8.6
81
404
ZX121
NOMESCO Finland
Central venous catheter
16.6
8.6
13
8
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.5
8.5
21
33
R2110
NOMESCO Finland
Giving the first information
2.7
8.5
46
178
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.5
301
2243
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
27.9
8.5
11
*
Z94.2
ICD-10 Finland
Lung transplant status
27.9
8.5
11
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
7.5
8.5
19
26
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
7.5
8.5
19
26
L04AX05
ATC
pirfenidone; oral
20.3
8.5
12
6
C08CA01
ATC
amlodipine; oral
1.6
8.5
279
2043
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.0
8.4
14
11
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.1
8.4
23
58
R03BB04
ATC
tiotropium bromide; inhalant
2.1
8.4
84
429
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
7.2
8.3
19
27
L01BC06
ATC
capecitabine; oral
2.9
8.3
40
146
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
8.2
43
164
A07EA06
ATC
budesonide; oral, local oral
3.3
8.2
31
98
J01AA02
ATC
doxycycline; systemic
1.7
8.2
505
4309
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
8.2
54
231
SPAT1262
SPAT
Handing over of treatment supplies
1.8
8.2
134
810
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.3
8.1
17
21
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.0
8.1
19
28
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.0
8.1
19
28
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
11.9
8.1
14
12
L01EL01
ATC
ibrutinib; oral
33.8
8.1
10
*
J47
ICD-10 Finland
Bronchiectasis
3.7
8.1
25
69
ZX080
NOMESCO Finland
Image guided radiotherapy
3.7
8.1
25
69
RS221, ,
NOMESCO Finland
6.4
8.1
20
32
ED1AA
NOMESCO Finland
Mandibular X-ray examination
10.2
8.1
15
15
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.0
248
1781
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.5
8.0
27
79
WVA20
NOMESCO Finland
Medicine administration
3.4
8.0
29
89
J46
ICD-10 Finland
Status asthmaticus
4.0
7.9
22
56
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
13.2
7.9
13
10
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
7.9
37
133
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.3
7.8
20
48
SPAT1325
SPAT
Vaccination
1.6
7.8
240
1720
FM1FN
NOMESCO Finland
Heart function isotope examination
15.2
7.7
12
8
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
45.5
7.7
9
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
45.5
7.7
9
*
B73
ICPC
Leukaemia
45.5
7.7
9
*
K65.0
ICD-10 Finland
Acute peritonitis
6.8
7.6
18
27
RS220, ,
NOMESCO Finland
6.8
7.6
18
27
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
25.3
7.6
10
*
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
25.3
7.6
10
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
25.3
7.6
10
*
NG1DA
NOMESCO Finland
X-ray of knees
4.2
7.6
20
49
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
7.6
43
171
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
7.6
76
388
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
7.5
38
142
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.7
7.5
39
148
EBA10
NOMESCO Finland
Operative extraction of tooth
2.1
7.5
72
361
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.6
7.5
43
172
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.3
7.5
28
88
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.3
7.5
28
88
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.5
7.5
25
73
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
7.8
7.4
16
21
XQ855, ,
SPAT
7.8
7.4
16
21
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
7.4
36
132
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.7
7.4
23
64
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
7.3
24
69
N03AX14
ATC
levetiracetam; systemic
3.3
7.3
27
84
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
11.0
7.3
13
12
B05DB
ATC
Hypertonic solutions
9.5
7.3
14
15
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
9.5
7.3
14
15
TGD00
NOMESCO Finland
Needle biopsy of lung
9.5
7.3
14
15
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
ZX131
NOMESCO Finland
Intrathecal
+∞
7.3
7
*
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
V03AE01
ATC
polystyrene sulfonate; oral
6.4
7.3
18
29
R04.2
ICD-10 Finland
Haemoptysis
3.0
7.3
32
111
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
15.9
7.2
11
7
WX722
NOMESCO Finland
PEEP
2.6
7.2
43
175
1CD02, ,
NOMESCO Finland
7.4
7.2
16
22
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.6
7.2
17
38
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
7.2
27
85
GDG10
NOMESCO Finland
Bilateral transplantation of lung
30.4
7.2
9
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.1
7.1
18
30
TPX15
NOMESCO Finland
Removal of vascular injection port
12.2
7.1
12
10
WPB10
NOMESCO Finland
Making a convalescent care decision
12.2
7.1
12
10
V03AE03
ATC
lanthanum carbonate; oral
12.2
7.1
12
10
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.0
7.0
30
102
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
7.1
7.0
16
23
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.9
7.0
20
52
R02
ICPC
Shortness of breath/dyspnoea
1.9
7.0
96
548
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.6
6.9
22
62
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
14.0
6.9
11
8
Z49.2
ICD-10 Finland
Other dialysis
8.4
6.9
14
17
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
8.4
6.9
14
17
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.8
6.8
16
24
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
11.1
6.8
12
11
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.4
6.8
13
14
GX1K5
NOMESCO Finland
Diffusion capacity
9.4
6.8
13
14
A41.8
ICD-10 Finland
Other specified sepsis
3.7
6.8
21
58
L01BB01, ,
ATC
40.5
6.8
8
*
L04AA37
ATC
[U] baricitinib
40.5
6.8
8
*
3006
Kela drug reimbursment
Baricitinib
40.5
6.8
8
*
293
Kela drug reimbursment
Baricitinib
40.5
6.8
8
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
16.9
6.8
10
6
P01AB01
ATC
metronidazole; oral, rectal
1.6
6.8
246
1820
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.5
6.7
23
68
J01FA06
ATC
roxithromycin; oral
1.6
6.7
254
1896
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
22.8
6.7
9
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
6.5
6.7
16
25
WF002
NOMESCO Finland
Radical radiotherapy
2.3
6.7
52
240
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.1
6.7
18
45
ZX100
NOMESCO Finland
Oral
4.1
6.7
18
45
H26.3
ICD-10 Finland
Drug-induced cataract
7.9
6.6
14
18
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
6.6
43
183
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.4
6.6
23
69
H05BX01
ATC
cinacalcet; oral
8.8
6.6
13
15
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.8
6.6
13
15
284
Kela drug reimbursment
Nintedanib and pirfenidone
10.2
6.6
12
12
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
10.2
6.6
12
12
J15.8
ICD-10 Finland
Other bacterial pneumonia
10.2
6.6
12
12
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.9
6.5
15
22
JAH01
NOMESCO Finland
Laparoscopy
2.8
6.5
32
118
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.7
6.5
20
55
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.0
6.5
28
96
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.8
6.5
17
30
B05DA
ATC
Isotonic solutions
7.5
6.4
14
19
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
70.5
6.4
7
*
WW402
NOMESCO Finland
Leucoferesis
70.5
6.4
7
*
L04AA10
ATC
[U] sirolimus
70.5
6.4
7
*
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
70.5
6.4
7
*
1AA09, ,
NOMESCO Finland
70.5
6.4
7
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
70.5
6.4
7
*
D07AC01
ATC
betamethasone; topical
1.6
6.4
231
1701
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
8.3
6.4
13
16
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.3
6.4
13
16
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
6.3
55
1041
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.2
6.3
11
10
TK820
NOMESCO Finland
Peritoneal dialysis
9.4
6.3
12
13
WX721
NOMESCO Finland
Oxygen concentrator therapy
18.2
6.3
9
5
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
6.3
6
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.1
6.3
25
82
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
26.9
6.2
8
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
26.9
6.2
8
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
26.9
6.2
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
26.9
6.2
8
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
26.9
6.2
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
6.2
52
247
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
6.2
33
127
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
4.0
6.2
17
43
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
6.2
30
110
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
6.1
128
824
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.7
6.1
10
8
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
12.7
6.1
10
8
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
6.1
55
270
L04AB06
ATC
golimumab; parenteral
8.7
6.1
12
14
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.8
6.1
14
21
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
6.0
185
1310

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
300
451
11.40
210.34
6.8
2.5
7.96
10.81
g/l
13.90
294
416
126
36
43.07
205.17
3.8
2.5
35.08
43.10
%
1.50
78
21
528
1668
12.03
186.32
11.7
4.4
—
—
—
0
0
348
714
9.24
184.22
2.3
1.5
—
—
—
0
0
212
261
11.52
170.31
3.2
2.1
0.92
2.59
ug/l
0.82
201
234
359
889
7.70
154.33
2.5
2.1
—
—
—
0
0
85
15
64.94
153.03
2.1
1.7
—
—
—
0
0
130
87
18.38
151.94
3.1
2.7
—
—
—
0
0
265
490
8.39
150.60
10.0
4.3
1.16
0.89
%
1.05
211
188
223
361
8.84
141.98
2.9
1.7
0.98
1.50
g/l
2.55
197
335
133
108
15.19
139.44
2.7
2.6
—
—
—
0
0
350
957
6.69
132.08
8.0
3.6
0.80
0.81
mmol/l
0.80
340
895
316
791
6.77
130.88
14.5
6.1
1.06
1.04
mmol/l
0.83
309
734
586
2611
12.51
129.63
25.6
6.3
—
—
—
0
0
583
2608
11.97
127.55
23.1
6.3
8.80
8.82
%
0.04
573
2450
295
713
6.69
126.14
2.0
1.7
—
—
—
0
0
88
38
26.58
124.21
3.5
1.8
513.81
682.87
e6/l
0.31
83
31
584
2657
11.78
124.12
22.3
6.1
24.60
27.18
%
3.90
575
2499
577
2601
11.01
123.53
22.0
5.9
2.15
2.90
%
14.89
567
2444
567
2519
10.13
122.98
21.5
5.9
0.58
0.66
%
2.56
559
2360
595
2776
13.12
122.68
19.9
5.8
0.04
0.04
e9/l
3.64
564
2414
594
2768
12.95
122.57
19.9
5.8
0.64
0.60
e9/l
2.78
562
2397
577
2614
10.92
122.42
20.5
5.9
60.34
57.38
%
4.62
570
2461
201
339
8.10
122.02
1.7
1.5
—
—
—
0
0
596
2829
12.92
119.19
20.3
5.8
2.13
2.01
e9/l
0.18
574
2512
597
2865
12.87
117.13
22.2
5.9
0.15
0.20
e9/l
11.97
574
2526
171
251
8.86
116.91
2.9
1.5
8.60
7.37
u/ml
—
14
7
119
109
13.11
115.21
2.3
1.6
—
—
—
0
0
218
441
6.90
110.40
10.0
4.2
0.61
0.61
%
0.01
165
155
70
22
35.49
109.57
1.2
1.5
—
—
—
0
0
221
459
6.75
108.85
10.6
4.4
0.16
0.13
%
0.33
167
156
109
103
12.49
103.09
1.5
1.4
89.58
99.80
u/ml
0.35
17
15
235
544
6.17
102.72
2.2
1.6
—
—
—
0
0
114
116
11.68
102.59
1.5
1.4
—
—
—
0
0
267
695
5.79
102.43
6.1
2.6
2.09
1.81
%
2.41
255
633
204
431
6.41
97.82
10.6
4.4
0.54
0.80
%
0.13
150
129
240
598
5.75
96.02
2.0
1.5
—
—
—
0
0
605
3251
11.88
95.63
39.2
9.3
4.33
4.13
e9/l
1.27
585
2862
525
2499
6.48
94.49
13.6
5.2
32.74
35.21
g/l
15.48
510
2339
90
72
14.33
94.17
1.6
1.3
—
—
—
0
0
430
1748
5.23
93.96
13.2
4.1
7.40
7.40
ph
0.31
125
321
222
527
5.85
93.52
5.8
2.7
74.80
71.23
e9/l
0.55
169
417
580
3045
8.72
92.27
20.8
6.6
9.85
11.56
umol/l
4.90
572
2895
106
115
10.80
90.87
6.4
4.1
—
—
—
0
0
256
722
5.17
87.63
11.3
8.2
4.78
5.13
kpa
7.70
244
692
256
722
5.17
87.63
11.3
8.2
10.46
11.96
kpa
5.69
244
694
558
2923
7.03
86.00
23.4
7.3
1.20
1.21
mmol/l
3.77
474
2499
151
273
6.88
83.90
2.5
2.1
1.53
1.49
g/l
0.16
126
239
251
720
5.02
83.66
11.3
8.3
1.16
1.26
mmol/l
0.15
202
574
98
108
10.49
82.85
1.3
1.3
269.80
269.82
u/ml
0.00
70
62
529
2712
5.88
81.77
19.2
6.3
1.20
1.21
mmol/l
3.33
517
2460
115
159
8.56
81.38
1.4
1.3
—
—
—
0
0
207
535
5.19
77.67
1.7
1.4
—
—
—
0
0
182
433
5.43
75.02
6.8
6.1
—
—
—
0
0
316
1172
4.27
73.59
5.0
3.1
527.79
552.86
mosm/kgh2o
1.44
304
1007
96
122
9.04
72.54
3.4
3.0
14.86
15.91
%
1.12
56
67
208
568
4.90
72.50
9.5
4.0
1.92
1.99
mmol/l
0.10
181
470
251
801
4.45
71.46
4.3
2.5
22.19
22.82
%
0.29
223
673
256
834
4.39
70.80
4.2
2.5
2.12
2.29
g/l
4.84
246
774
87
103
9.58
69.41
2.1
1.5
—
—
—
0
0
194
517
4.91
69.41
3.1
2.2
359.76
376.62
nmol/l
0.33
187
479
266
910
4.23
68.46
4.2
2.6
11.53
12.81
umol/l
2.44
258
844
317
1228
4.06
68.38
4.5
2.6
3.98
4.81
e6/l
0.57
308
1109
219
656
4.51
67.31
11.6
8.6
94.23
95.47
%
1.55
210
632
82
96
9.62
65.90
7.8
3.4
1.45
1.23
%
0.17
77
89
389
1778
3.91
64.84
6.3
3.3
58.60
99.13
e6/l
0.39
349
1394
65
56
12.77
64.54
1.1
1.2
—
—
—
0
0
512
2841
4.63
63.78
17.3
14.9
1.19
1.28
inr
1.60
167
805
65
58
12.33
63.11
2.3
2.3
—
—
—
0
0
60
49
13.38
61.51
1.6
1.1
—
—
—
0
0
364
1642
3.73
60.81
6.2
3.3
0.26
0.54
e6/l
2.94
324
1262
463
2458
3.99
59.88
35.5
9.8
0.01
0.00
e9/l
0.59
414
2024
163
429
4.72
58.41
5.9
2.6
—
—
—
0
0
41
17
25.66
57.98
2.7
1.4
—
—
—
0
0
350
1576
3.61
57.88
6.1
3.2
—
—
—
0
0
215
701
4.07
57.87
1.7
1.3
338.95
461.64
titre
0.87
57
159
347
1555
3.61
57.80
8.6
2.8
3598.98
7390.70
umol/l
0.95
329
1343
40
16
26.56
57.29
1.5
1.3
—
—
—
0
0
408
2043
3.63
56.63
7.4
3.9
24.79
90.87
e6/l
3.04
354
1486
195
616
4.08
54.52
13.3
8.9
113.77
121.19
g/l
4.52
189
600
56
50
12.15
54.21
1.6
1.4
1.90
2.71
g/l
1.62
38
37
56
50
12.15
54.21
1.6
1.4
0.41
0.42
g/l
0.06
34
37
56
50
12.15
54.21
1.6
1.4
6.25
8.23
g/l
0.83
35
38
550
3406
4.77
54.19
14.0
5.1
6.82
6.78
mmol/l
0.17
540
3207
266
1050
3.58
53.23
2.9
1.5
2.23
2.57
g/l
1.18
211
625
173
511
4.24
52.92
13.5
8.4
—
—
—
0
0
55
52
11.45
51.25
1.6
1.4
—
—
—
0
0
69
90
8.45
50.63
1.5
1.8
0.36
0.88
g/l
2.26
45
70
316
1425
3.35
50.42
27.3
6.7
—
—
—
0
0
73
103
7.85
50.12
7.5
3.6
57.58
57.42
%
0.02
73
103
285
1219
3.36
49.45
2.4
1.6
2.00
1.36
mg/l
0.87
249
946
385
1970
3.31
49.33
9.9
3.6
2.32
2.35
mmol/l
3.87
367
1714
56
58
10.46
48.98
1.5
1.2
—
—
—
0
0
83
143
6.50
47.33
2.5
1.7
—
—
—
0
0
90
170
5.98
46.74
5.9
3.9
1.96
1.60
mg/l
2.54
85
155
142
395
4.31
46.66
5.8
3.7
7.43
7.41
ph
2.23
34
52
142
403
4.22
45.34
5.8
3.7
4.95
5.12
kpa
1.45
137
385
357
1832
3.08
43.96
4.6
3.0
2109.78
1331.99
ng/l
1.81
332
1573
70
109
7.07
43.89
5.0
2.8
—
—
—
0
0
52
57
9.82
43.58
1.2
1.2
—
—
—
0
0
94
197
5.40
43.53
8.5
3.7
63.49
89.75
mg/l
0.34
72
156
73
121
6.66
43.13
8.9
4.9
2.63
2.45
mmol/l
0.19
60
85
36
22
17.25
42.97
1.3
1.2
—
—
—
0
0
352
1811
3.03
42.82
3.7
2.6
66.23
59.35
u/l
0.55
335
1677
113
281
4.65
42.71
1.6
1.3
—
—
—
0
0
93
197
5.33
42.53
8.6
3.7
54.47
34.55
mg/l
1.40
72
159
92
194
5.35
42.28
8.5
3.6
27.96
2.12
ratio
—
5
18
551
3713
4.00
41.10
7.7
4.5
1576.90
2157.52
e6/l
—
10
58
75
136
6.10
40.48
3.6
2.4
118.44
128.85
g/l
2.31
57
97
182
680
3.32
38.03
2.2
1.7
—
—
—
0
0
50
64
8.37
37.08
1.4
1.2
—
—
—
0
0
75
148
5.59
36.96
9.0
3.8
—
—
—
0
0
290
1434
2.83
36.49
2.9
2.2
3.34
3.10
mg/l
0.97
268
1211
332
1766
2.78
36.17
4.0
3.1
—
—
—
0
0
133
421
3.71
35.85
13.1
8.4
24.43
24.54
mmol/l
0.11
125
401
442
2743
2.87
35.26
8.3
5.0
0.00
0.00
estimate
-0.00
136
509
442
2745
2.86
35.17
6.3
3.8
0.00
0.00
estimate
0.50
144
545
552
3886
3.63
34.82
9.0
4.3
—
—
—
0
0
333
1803
2.72
34.60
7.7
3.5
36.37
32.76
u/l
0.49
326
1713
443
2781
2.82
34.04
6.3
3.8
0.00
0.00
estimate
-0.00
132
485
56
90
6.71
33.94
6.2
6.7
11.62
11.23
mg/l
0.21
51
83
78
174
4.95
33.38
2.0
1.4
0.24
0.23
g/l
0.38
73
165
156
577
3.23
32.68
2.6
2.3
0.23
0.21
g/l
1.58
142
538
281
1449
2.64
31.49
10.0
4.0
89.05
89.01
%
0.01
270
1424
168
662
3.07
31.47
6.8
3.0
6.29
9.24
umol/l
1.72
152
588
111
342
3.70
30.90
18.9
11.5
—
—
—
0
0
54
92
6.31
30.89
4.6
2.1
—
—
—
0
0
564
4151
3.53
30.33
11.7
4.2
22.25
12.76
mm/h
20.65
556
3797
371
2234
2.52
29.34
4.9
2.7
353.80
149.46
ug/l
2.95
357
2027
365
2183
2.51
29.27
5.2
3.5
5.83
5.74
ph
—
6
142
418
2675
2.55
28.75
6.1
2.7
—
—
—
0
0
101
308
3.69
28.45
2.1
1.2
175.63
264.63
u/ml
0.47
90
280
45
70
6.83
28.06
12.4
3.6
—
—
—
0
0
228
1121
2.58
27.48
5.5
3.9
181.73
274.65
ng/l
0.53
205
923
217
1046
2.60
27.21
4.8
2.9
0.99
1.01
e6/l
0.03
145
614
61
131
5.03
27.19
1.5
1.2
—
—
—
0
0
89
258
3.83
26.94
5.9
4.7
—
—
—
0
0
318
1843
2.41
26.55
5.8
2.5
—
—
—
0
0
134
509
3.05
26.40
3.6
3.0
166.22
199.84
ng/l
0.51
124
466
97
305
3.56
26.01
7.0
2.8
1.22
1.21
%
0.03
97
305
124
455
3.13
25.90
6.8
4.1
108.50
84.69
ng/l
1.92
117
407
201
973
2.54
24.62
5.4
3.1
1.38
1.95
e6/l
0.85
130
547
68
176
4.19
24.00
4.2
3.0
—
—
—
0
0
218
1116
2.43
23.48
5.1
3.3
2.47
2.45
mmol/l
0.93
202
976
356
2263
2.25
22.79
3.5
2.3
77.65
77.84
nmol/l
0.04
345
1987
120
466
2.93
22.50
7.0
3.7
—
—
—
0
0
46
91
5.36
22.45
1.1
1.1
—
—
—
0
0
357
2283
2.23
22.38
6.2
3.8
31.05
43.72
ng/l
1.36
309
1694
29
10
30.25
22.03
1.2
1.5
—
—
—
0
0
129
527
2.80
21.98
3.8
2.4
38.31
33.29
u/l
0.57
116
444
44
87
5.35
21.48
4.7
2.0
32.73
32.93
pg
0.11
44
87
255
1446
2.25
21.23
1.9
1.5
18.40
20.59
nmol/l
1.57
234
1210
46
96
5.08
21.13
1.2
1.1
—
—
—
0
0
35
60
6.11
19.82
5.0
2.4
—
—
—
0
0
82
279
3.22
19.22
1.6
1.7
—
—
—
0
0
29
43
7.01
18.83
2.8
1.7
—
—
—
0
0
73
237
3.34
18.45
5.4
4.1
1.52
1.37
mmol/l
0.52
68
232
34
61
5.82
18.38
1.2
1.2
—
—
—
0
0
28
19
15.33
17.27
1.2
1.2
—
—
—
0
0
28
44
6.60
17.22
1.5
1.2
90.00
110.00
titre
—
6
9
239
1415
2.08
17.04
5.3
2.4
—
—
—
0
0
41
94
4.59
16.84
1.2
1.1
—
—
—
0
0
32
60
5.56
16.52
1.1
1.1
—
—
—
0
0
329
2210
1.98
16.25
2.5
2.1
—
—
—
0
0
246
1509
2.01
15.63
6.8
4.1
0.00
0.01
estimate
0.50
117
487
22
10
22.70
15.62
1.0
1.1
—
—
—
0
0
241
1468
2.01
15.61
6.1
3.4
—
—
—
0
0
277
1777
1.97
15.42
3.6
2.2
109.86
254.04
u/l
2.59
266
1672
134
656
2.31
15.22
5.3
4.3
18.22
34.74
ug/l
0.42
111
557
41
102
4.22
15.19
6.0
2.9
—
—
—
0
0
192
1098
2.06
14.66
1.7
1.7
1227.49
1204.55
nmol/l
0.11
161
831
40
101
4.15
14.53
1.8
1.2
—
—
—
0
0
218
1311
1.99
14.43
5.6
3.8
—
—
—
0
0
29
58
5.18
13.95
1.6
1.1
—
—
—
0
0
26
47
5.72
13.93
1.2
1.1
—
—
—
0
0
624
5490
3.72
13.77
68.3
15.4
26.59
25.11
mg/l
0.80
612
4390
29
59
5.10
13.69
1.6
1.1
—
—
—
0
0
43
124
3.64
13.00
1.8
1.2
4.31
11.28
e6/l
0.60
36
97
228
1441
1.89
12.73
1.7
1.4
—
—
—
0
0
22
18
12.60
12.68
1.9
2.1
—
—
—
0
0
16
5
32.73
12.62
1.9
1.0
—
—
—
0
0
16
5
32.73
12.62
1.9
1.0
—
—
—
0
0
16
5
32.73
12.62
1.9
1.0
—
—
—
0
0
17
7
24.86
12.51
1.9
1.0
—
—
—
0
0
501
4065
1.98
12.37
6.7
4.1
—
—
—
0
0
50
166
3.18
12.14
1.4
1.2
—
—
—
0
0
43
132
3.42
11.84
9.8
2.9
—
—
—
0
0
156
887
1.99
11.80
1.3
1.3
46.85
13.11
u/ml
1.70
41
339
20
16
12.85
11.69
1.0
1.0
—
—
—
0
0
56
209
2.84
11.10
14.2
9.1
1.38
1.29
mmol/l
0.43
50
183
20
35
5.86
11.06
1.4
1.3
—
—
—
0
0
19
16
12.19
10.89
4.4
5.4
—
—
—
0
0
19
16
12.19
10.89
1.2
1.1
—
—
—
0
0
157
922
1.92
10.70
1.3
1.3
72.09
38.15
iu/ml
1.40
62
275
69
293
2.51
10.61
6.9
3.8
—
—
—
0
0
43
144
3.13
10.30
2.5
3.4
31.47
34.38
umol/l
0.41
38
130
34
98
3.60
10.30
1.1
1.4
213.72
181.93
miu/ml
—
5
37
105
541
2.12
10.28
2.4
2.5
7.36
6.24
ug/l
0.29
94
483
20
22
9.34
10.07
3.4
2.0
—
—
—
0
0
328
2430
1.70
10.00
2.3
2.0
90.23
94.67
pmol/l
1.00
217
1239
15
9
17.02
9.91
1.5
1.2
—
—
—
0
0
20
39
5.26
9.89
1.5
1.2
5.54
0.25
u/ml
—
10
24
36
112
3.34
9.72
11.2
2.6
59.37
61.48
%
0.22
36
112
19
36
5.41
9.68
1.7
4.7
7.43
7.42
ph
0.15
13
12
20
24
8.56
9.61
2.3
2.1
61.15
74.22
ug/l
0.24
20
24
17
15
11.60
9.60
1.1
1.1
—
—
—
0
0
17
15
11.60
9.60
1.1
1.1
—
—
—
0
0
17
15
11.60
9.60
1.1
1.1
—
—
—
0
0
25
61
4.22
9.51
4.6
2.9
1.28
1.58
g/24h
0.13
16
32
19
37
5.26
9.41
1.6
3.5
—
—
—
0
0
21
45
4.79
9.35
1.5
1.1
—
—
—
0
0
19
39
4.99
8.88
5.1
3.3
—
—
—
0
0
53
216
2.58
8.87
5.5
3.6
0.31
0.22
g/l
0.33
45
96
18
22
8.38
8.62
2.5
2.1
—
—
—
0
0
20
30
6.84
8.41
1.9
1.5
—
—
—
0
0
56
241
2.45
8.37
1.5
1.3
—
—
—
0
0
26
73
3.67
8.20
1.7
1.3
2667.10
1401.73
e6/l
0.66
21
48
14
12
11.89
8.10
1.4
1.5
—
—
—
0
0
68
326
2.21
7.95
3.8
2.8
0.22
0.24
e6/l
0.06
68
320
32
106
3.12
7.84
1.8
1.2
32.98
32.34
u/ml
—
8
10
428
3519
1.62
7.78
5.5
3.3
82.02
54.49
u/l
3.74
409
3238
27
81
3.43
7.73
1.4
1.2
4.20
7.34
u/ml
—
10
38
18
27
6.82
7.63
1.0
1.0
—
—
—
0
0
11
6
18.61
7.62
2.7
3.5
—
—
—
0
0
22
59
3.82
7.41
1.7
1.3
—
—
—
0
0
13
12
11.02
7.32
1.7
1.5
—
—
—
0
0
112
661
1.84
7.32
1.3
1.3
—
—
—
0
0
129
796
1.77
7.27
1.4
1.2
—
—
—
0
0
23
65
3.63
7.20
1.8
1.3
12760.87
49622.66
e6/l
1.00
15
35
18
30
6.14
7.11
1.0
1.0
—
—
—
0
0
31
108
2.96
6.99
1.5
1.5
—
—
—
0
0
12
11
11.09
6.82
1.8
1.3
—
—
—
0
0
89
502
1.89
6.68
5.9
3.4
—
—
—
0
0
59
287
2.16
6.66
5.5
3.8
—
—
—
0
0
91
518
1.88
6.64
2.7
1.4
—
—
—
0
0
22
64
3.52
6.61
1.6
1.4
—
—
—
0
0
10
7
14.48
6.41
1.0
1.1
—
—
—
0
0
25
81
3.17
6.38
4.9
3.0
4.23
4.04
mmol/l
0.84
25
81
20
56
3.65
6.36
5.0
3.0
—
—
—
0
0
20
58
3.53
6.05
1.8
1.2
43.08
31.35
%
0.54
13
40
621
5786
2.34
6.04
65.0
18.3
138.50
139.69
mmol/l
22.22
621
5635
16
40
4.07
5.92
1.7
1.3
—
—
—
0
0
64
337
2.00
5.87
5.0
3.0
4.45
5.21
e9/l
0.38
58
270
24
80
3.08
5.86
5.0
3.0
—
—
—
0
0
17
35
4.96
5.77
1.3
1.2
5.74
7.07
u/l
0.37
12
29
16
41
3.97
5.74
1.1
1.2
—
—
—
0
0
24
81
3.04
5.74
5.0
3.0
106.17
105.20
mmol/l
0.42
24
81
23
76
3.10
5.70
4.6
2.1
5562.65
2484.89
u/l
0.21
11
27
11
13
8.58
5.57
1.3
1.1
—
—
—
0
0
51
252
2.11
5.56
4.4
3.7
566.50
5632.53
u/ml
0.69
46
216
48
234
2.13
5.42
2.5
1.7
—
—
—
0
0
9
8
11.38
5.30
1.3
1.0
—
—
—
0
0
174
1248
1.54
5.27
1.6
1.7
70667123.23
18559167.67
pmol/l
0.33
150
1013
26
98
2.72
5.13
1.5
1.4
—
—
—
0
0
31
128
2.49
5.12
1.7
1.5
11.93
7.55
u/l
0.70
23
97
17
50
3.46
5.05
19.1
2.2
8.34
10.49
%
1.51
17
50
232
1781
1.47
5.02
5.6
4.0
—
—
—
0
0
37
168
2.27
4.97
1.4
1.5
241.87
284.03
ug/g
0.59
23
98
611
5715
1.99
4.94
47.7
14.7
—
—
—
0
0
8
7
11.55
4.79
6.3
3.4
17.95
37.14
g/mol
—
8
7
35
159
2.27
4.71
1.4
1.2
123.33
45.00
titre
—
6
8
7
5
14.13
4.58
1.3
1.0
—
—
—
0
0
8
8
10.10
4.53
3.8
2.6
—
—
—
0
0
51
277
1.91
4.32
2.4
3.3
3.86
4.50
pmol/l
3.85
44
233
27
115
2.41
4.21
1.8
1.5
40.92
26.45
iu/l
0.83
21
97
55
309
1.85
4.21
2.2
2.4
—
—
—
0
0
14
41
3.47
4.20
1.4
1.1
—
—
—
0
0
10
17
5.96
4.14
1.1
1.2
—
—
—
0
0
71
434
1.71
4.10
1.8
1.4
—
—
—
0
0
36
176
2.11
4.08
1.4
1.3
—
634.00
—
0
5
8
10
8.08
4.07
4.1
2.8
—
—
—
0
0
19
69
2.81
4.05
2.2
1.3
49.09
63.42
%
0.63
11
45
12
28
4.35
3.83
2.2
1.4
47.41
61.16
%
0.59
12
19
106
730
1.54
3.79
1.4
1.3
—
—
—
0
0
6
5
12.09
3.77
1.3
1.2
—
—
—
0
0
93
626
1.57
3.68
3.6
2.3
254.61
128.01
ug/g
1.35
79
490
9
16
5.69
3.67
2.7
1.9
—
—
—
0
0
460
4117
1.39
3.64
4.5
3.8
14.89
14.95
pmol/l
0.16
434
3673
165
1253
1.42
3.61
6.2
4.1
1.02
1.02
kg/l
0.13
20
178
13
37
3.56
3.42
1.5
3.4
—
—
—
0
0
7
10
7.06
3.37
1.1
1.1
—
—
—
0
0
228
1848
1.36
3.34
6.0
3.3
1824.07
239.09
mg/l
1.98
173
1209
6
7
8.64
3.27
1.3
1.0
—
—
—
0
0
6
7
8.64
3.27
1.3
1.0
—
—
—
0
0
9
19
4.79
3.24
1.2
1.2
—
23.60
u/ml
—
0
5
235
1921
1.35
3.24
5.2
3.2
6.71
7.71
mmol/l
2.89
215
1603
17
66
2.62
3.23
2.3
1.4
—
—
—
0
0
7
11
6.42
3.19
12.1
9.5
5.31
6.25
mmol/l
—
7
11
30
152
2.02
3.14
2.3
1.6
7502.55
15016.64
e6/l
0.86
22
107
31
160
1.98
3.09
6.5
5.0
—
—
—
0
0
10
25
4.05
3.09
2.3
1.3
5.50
1.21
%
—
10
18
8
16
5.05
3.06
1.0
1.2
—
—
—
0
0
11
31
3.59
3.00
4.2
6.0
—
—
—
0
0
8
17
4.75
2.92
1.0
1.2
—
—
—
0
0
9
22
4.13
2.89
2.3
1.1
20.33
29.88
%
—
9
17
11
33
3.37
2.82
1.3
1.3
—
—
—
0
0
10
28
3.61
2.79
2.4
1.3
141.40
149.30
nmol/l
—
10
28
9
23
3.95
2.78
1.3
1.2
2.15
3.75
mmol/l
—
9
18
5
6
8.38
2.75
1.8
1.2
—
—
—
0
0
17
72
2.40
2.74
1.2
1.1
—
—
—
0
0
9
232
0.38
2.72
1.3
1.5
—
—
—
0
0
233
1949
1.30
2.63
5.7
3.9
13.81
8.85
mg/mmol
1.25
173
1244
17
74
2.33
2.60
2.9
1.6
—
—
—
0
0
27
142
1.94
2.59
3.6
2.3
—
—
—
0
0
24
121
2.02
2.58
2.3
3.0
0.97
0.91
nmol/l
0.14
17
92
13
50
2.63
2.54
2.7
1.9
0.75
2.68
u/field
—
8
19
13
51
2.58
2.45
1.5
1.2
—
—
—
0
0
38
228
1.71
2.42
4.3
3.3
48.11
62.93
u/ml
0.20
38
219
20
383
0.51
2.40
1.2
1.4
—
—
—
0
0
7
18
3.92
2.25
1.0
1.2
—
—
—
0
0
19
93
2.07
2.23
1.5
1.4
—
—
—
0
0
23
121
1.93
2.23
3.7
3.9
489.69
2407.77
u/ml
0.46
23
114
12
48
2.53
2.19
1.8
1.2
—
—
—
0
0
628
6087
1.72
2.18
87.5
22.8
36.79
40.23
%
35.99
590
5638
628
6087
1.72
2.18
86.1
22.6
93.04
91.34
fl
13.10
628
5985
628
6088
1.71
2.17
86.0
22.6
30.65
30.41
pg
2.36
628
5986
7
19
3.71
2.15
1.0
1.1
—
—
—
0
0
6
14
4.31
2.15
6.8
7.1
—
—
—
0
0
11
42
2.65
2.15
1.0
1.1
286.83
368.57
nmol/l
—
6
35
7
20
3.53
2.06
1.3
1.1
—
—
—
0
0
7
22
3.20
1.88
2.9
1.4
—
—
—
0
0
5
12
4.19
1.82
5.8
7.7
—
—
—
0
0
0
49
0.00
1.69
0.0
1.0
—
267.50
—
0
28
7
164
0.42
1.68
2.0
1.6
—
—
—
0
0
541
5627
0.78
1.58
5.5
5.3
2.58
2.68
mmol/l
1.83
491
5117
52
374
1.42
1.58
3.4
2.6
—
—
—
0
0
14
71
1.99
1.55
1.3
1.2
—
—
—
0
0
114
1384
0.79
1.54
2.2
3.1
0.73
0.75
ug/l
0.09
76
952
140
1173
1.25
1.49
1.2
1.3
0.77
1.41
u/ml
1.64
34
303
9
40
2.27
1.40
1.0
1.2
—
2.66
—
0
5
34
233
1.48
1.34
1.1
1.1
—
28.50
—
0
6
20
122
1.66
1.28
6.2
3.8
34.87
24.81
mg/l
0.47
15
73
20
122
1.66
1.28
1.3
1.4
—
—
—
0
0
5
115
0.43
1.26
1.0
1.6
—
—
—
0
0
7
31
2.27
1.10
1.1
1.1
—
—
—
0
0
7
31
2.27
1.10
1.3
1.1
3.90
5.48
ug/l
—
7
25
5
21
2.39
1.09
2.6
3.0
—
—
—
0
0
12
67
1.81
1.05
1.7
2.8
3.42
5.91
nmol/l
0.51
12
67
159
1798
0.85
1.05
3.8
3.1
—
—
—
0
0
7
34
2.07
1.03
3.3
1.8
—
—
—
0
0
9
47
1.93
1.02
1.3
1.4
40.27
30.16
u/l
—
9
38
523
5036
1.19
1.02
5.5
4.6
2.24
1.97
mu/l
1.04
486
4532
44
336
1.33
1.00
1.4
1.4
—
—
—
0
0
7
36
1.95
0.97
4.0
1.4
0.91
0.98
g/l
—
7
36
7
37
1.90
0.94
1.4
2.0
—
—
—
0
0
12
70
1.73
0.93
1.1
1.3
—
—
—
0
0
6
30
2.01
0.87
1.2
1.3
—
—
—
0
0
6
32
1.88
0.82
1.7
1.6
121.42
157.43
pmol/l
—
6
32
24
173
1.40
0.80
1.0
1.1
—
—
—
0
0
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
6
33
1.83
0.79
1.0
1.0
—
—
—
0
0
9
55
1.65
0.73
1.1
1.2
—
—
—
0
0
34
264
1.30
0.73
2.2
3.0
—
—
—
0
0
10
159
0.62
0.73
1.0
1.2
—
—
—
0
0
7
41
1.71
0.70
1.0
3.4
8.56
7.23
mmol/l
—
7
25
40
320
1.27
0.69
1.1
1.2
29.29
150.15
iu/ml
5.81
12
122
533
5464
0.87
0.69
5.0
4.6
1.37
1.44
mmol/l
3.54
488
4964
537
5502
0.87
0.69
5.2
4.7
4.46
4.56
mmol/l
1.45
496
5034
7
43
1.63
0.67
1.0
1.0
—
—
—
0
0
55
461
1.21
0.64
2.7
2.3
10.82
12.78
nmol/l
0.92
47
410
5
30
1.67
0.61
1.4
1.1
261.80
184.36
mmol/24h
—
5
30
8
52
1.54
0.59
1.1
1.2
1.22
1.64
nmol/l
—
8
46
6
35
1.72
0.58
1.2
1.1
—
8.13
—
0
9
6
37
1.63
0.55
1.2
1.4
—
—
—
0
0
10
66
1.52
0.52
1.2
1.3
—
—
—
0
0
13
180
0.72
0.52
22.7
10.8
—
—
—
0
0
22
171
1.30
0.50
2.1
2.5
188.73
114.06
ug/min
0.47
15
95
10
68
1.48
0.47
1.1
1.3
—
—
nmol/l
—
0
0
172
1607
1.10
0.45
1.8
1.7
1.61
1.36
mmol/l
2.83
150
1330
47
406
1.17
0.43
1.1
1.2
—
—
—
0
0
8
57
1.41
0.42
10.5
1.5
—
—
—
0
0
11
150
0.73
0.42
1.1
1.1
—
—
—
0
0
538
5465
0.91
0.37
5.7
4.9
6.08
6.04
mmol/l
0.24
500
4922
12
156
0.76
0.35
1.8
1.8
48.00
41.16
nmol/l
0.29
12
149
13
104
1.26
0.26
1.1
1.2
—
—
—
0
0
518
5244
0.94
0.23
7.3
6.2
40.37
40.32
mmol/mol
0.04
493
4822
5
41
1.22
0.22
1.2
1.4
1.06
1.39
promille
—
5
33
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
19.33
—
0
12
17
195
0.87
0.18
1.0
1.1
—
—
—
0
0
6
77
0.78
0.15
1.0
1.1
—
16.80
—
0
15
6
78
0.77
0.15
14.2
1.7
—
—
—
0
0
62
589
1.06
0.13
16.0
4.3
—
—
—
0
0
9
110
0.82
0.13
2.2
1.9
171.67
222.67
pmol/l
—
9
103
13
114
1.14
0.12
6.9
1.3
—
—
—
0
0
37
348
1.07
0.11
1.2
1.3
—
—
—
0
0
13
115
1.13
0.10
6.9
1.3
—
—
—
0
0
13
115
1.13
0.10
6.9
1.3
—
—
—
0
0
13
115
1.13
0.10
6.9
1.3
—
—
—
0
0
246
2421
1.03
0.10
4.5
5.2
3.15
2.64
ug/l
0.36
224
2150
57
547
1.05
0.09
1.5
1.5
—
—
—
0
0
12
110
1.09
0.05
7.4
1.3
—
—
—
0
0
18
185
0.97
0.00
2.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
526
5260
1.00
-0.00
5.0
4.2
1.44
1.30
mmol/l
3.85
480
4746
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
31.67
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
9
93
0.97
-0.00
9.4
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PNEUMOCYSTOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 10.609 [7.15, 15.75] < 0.001
Birth year 1.003 [0.99, 1.01] 0.449

During the follow-up period (1.1.1998 — 31.12.2019), 296 out of 647 females with AB1_PNEUMOCYSTOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 5.697 [4.03, 8.05] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 404 out of 853 males with AB1_PNEUMOCYSTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_PNEUMOCYSTOSIS.

N-year risk Females Males
1 1.668% 1.058%
5 7.866% 6.012%
10 18.753% 14.416%
15 32.72% 25.087%
20 51.67% 40.573%

Relationships between endpoints

↥

Index endpoint: AB1_PNEUMOCYSTOSIS – Pneumocystosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data